Join

Compare · CERS vs PDD

CERS vs PDD

Side-by-side comparison of Cerus Corporation (CERS) and PDD Holdings Inc. (PDD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CERS and PDD operate in EDP Services (Technology), so they compete in similar markets.
  • PDD is the larger of the two at $96.87B, about 111.8x CERS ($866.5M).
  • Over the past year, CERS is up 47.8% and PDD is down 4.9% - CERS leads by 52.7 points.
  • CERS has been more active in the news (4 items in the past 4 weeks vs 1 for PDD).
  • PDD has more recent analyst coverage (25 ratings vs 3 for CERS).
PerformanceCERS+47.76%PDD-4.91%
2025-04-28+0.00%2026-04-24
MetricCERSPDD
Company
Cerus Corporation
PDD Holdings Inc.
Price
$1.98+4.49%
$98.02+0.25%
Market cap
$866.5M
$96.87B
1M return
+7.03%
-4.46%
1Y return
+47.76%
-4.91%
Industry
EDP Services
EDP Services
Exchange
NASDAQ
NASDAQ
IPO
1997
2018
News (4w)
4
1
Recent ratings
3
25
CERS

Cerus Corporation

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.

PDD

PDD Holdings Inc.

Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverage, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.